BRCA1/BRCA2突变男性接受前列腺癌筛查的心理社会影响
本研究为IMPACT研究的一部分,报告432名BRCA1/BRCA2突变携带者及对照男性在年度前列腺癌筛查前的基线心理社会问卷结果。总体上未发现临床关注的痛苦水平或生活质量下降,但携带者的事件影响量表侵入与回避评分显著高于对照,且风险感知对评分变异的贡献大于遗传状态。
要点
- BRCA1/BRCA2携带者前列腺癌筛查前总体心理痛苦未达临床关注水平。
- 携带者的事件影响量表侵入与回避评分显著高于对照。
- 风险感知较遗传状态更显著影响事件影响量表评分变异。
核心结论
- 整体队列未检测到临床关注水平的一般或癌症特异性痛苦或生活质量差。
- 小部分参与者报告较高痛苦水平,需医护人员识别风险因素并提供额外信息与支持。
研究设计与样本
- 纵向心理社会研究,作为IMPACT研究的一部分,在多国协作站点进行。
- 男性在每年筛查访视前完成问卷,包括社会人口学特征及HADS、IES、SF-36、Memorial焦虑量表、癌症担忧量表修订版、风险感知与知识。
- 共432名男性完成基线问卷:BRCA1突变98人,BRCA2突变160人,对照174人(家族突变阴性)。
主要发现
- 参与者对前列腺癌风险的感知受遗传状态影响。
- 知识水平高且与遗传状态无关。
- HADS和SF-36平均分在报告的一般人群正常范围内,IES平均分在正常范围内。
- BRCA1/BRCA2携带者的IES侵入和回避平均分显著高于对照,且在风险感知较高的男性中更高。
- 多变量分析中,风险感知对IES评分变异的贡献比遗传状态更显著。
临床怎么用
- 提供前列腺癌筛查的医护人员应识别痛苦风险因素,并向寻求筛查的男性提供额外信息和支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report the baseline results of a longitudinal psychosocial study that forms part of the IMPACT study, a multi-national investigation of targeted prostate cancer (PCa) screening among men with a known pathogenic germline mutation in the BRCA1 or BRCA2 genes. PARTICPANTS AND METHODS: Men enrolled in the IMPACT study were invited to complete a questionnaire at collaborating sites prior to each annual screening visit. The questionnaire included sociodemographic characteristics and the following measures: the Hospital Anxiety and Depression Scale (HADS), Impact of Event Scale (IES), 36-item short-form health survey (SF-36), Memorial Anxiety Scale for Prostate Cancer, Cancer Worry Scale-Revised, risk perception and knowledge. The results of the baseline questionnaire are presented. RESULTS: A total of 432 men completed questionnaires: 98 and 160 had mutations in BRCA1 and BRCA2 genes, respectively, and 174 were controls (familial mutation negative). Participants' perception of PCa risk was influenced by genetic status. Knowledge levels were high and unrelated to genetic status. Mean scores for the HADS and SF-36 were within reported general population norms and mean IES scores were within normal range. IES mean intrusion and avoidance scores were significantly higher in BRCA1/BRCA2 carriers than in controls and were higher in men with increased PCa risk perception. At the multivariate level, risk perception contributed more significantly to variance in IES scores than genetic status. CONCLUSION: This is the first study to report the psychosocial profile of men with BRCA1/BRCA2 mutations undergoing PCa screening. No clinically concerning levels of general or cancer-specific distress or poor quality of life were detected in the cohort as a whole. A small subset of participants reported higher levels of distress, suggesting the need for healthcare professionals offering PCa screening to identify these risk factors and offer additional information and support to men seeking PCa screening.
引用
- Bancroft EK, Saya S, Page EC, et al. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations. BJU Int. 2018. PMID: 29802810. doi:10.1111/bju.14412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。